title: HER2 testing: the patent "genee" is out of the bottle.
authors.affiliation: Department of Family and Community Medicine, University of Toronto, Mount Sinai Hospital, Toronto, ON. drhbg@rogers.com
authors.forename: Brian
authors.initials: B
authors.lastname: Goldman
mesh_terms: D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D002170:Canada; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D018734:Genes, erbB-2; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D010330:Patents as Topic; D000068878:Trastuzumab; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab